General information about company |
|||
|---|---|---|---|
| Scrip Code | 544309 | ||
| NSE Symbol | IKS | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE115Q01022 | ||
| Name of company | INVENTURUS KNOWLEDGE SOLUTIONS LIMITED | ||
| Type of company | Main Board | ||
| Class of security | Equity | ||
| Date of start of financial year | 01-Apr-2025 | ||
| Date of end of financial year | 31-Mar-2026 | ||
| Date of board meeting when results were approved | 31-Jul-2025 | ||
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 24-Jul-2025 | ||
| Description of presentation currency | INR (in Actuals) | ||
| Reporting Type | Quarterly | ||
| Reporting Quarter | First quarter | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Whether results are audited or unaudited for the quarter ended | Unaudited | ||
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |||
| Segment Reporting | Single segment | ||
| Description of single segment | CARE ENABLEMENT PLATFORM PROVIDING TECHNOLOGY ENABLED SOLUTIONS TO HEALTHCARE PROVIDERS | ||
| Start date and time of board meeting | 31-Jul-2025 19:30:00 | ||
| End date and time of board meeting | 31-Jul-2025 20:45:00 | ||
| Whether cash flow statement is applicable on company | |||
| Type of cash flow statement | |||
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable | ||
Financial Results Ind-AS |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Apr-2025 | |
| B | Date of end of reporting period | 30-Jun-2025 | |
| C | Whether results are audited or unaudited | Unaudited | |
| D | Nature of report standalone or consolidated | Consolidated | |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 7400950000 | ||
| Other income | 31130000 | ||
| Total income | 7432080000 | ||
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0 | |
| (b) | Purchases of stock-in-trade | 0 | |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0 | |
| (d) | Employee benefit expense | 3959620000 | |
| (e) | Finance costs | 180790000 | |
| (f) | Depreciation, depletion and amortisation expense | 279030000 | |
| (f) | Other Expenses | ||
| 1 | Other expenses | 1063820000 | 1063820000 |
| Total other expenses | 1063820000 | ||
| Total expenses | 5483260000 | ||
| 3 | Total profit before exceptional items and tax | 1948820000 | |
| 4 | Exceptional items | 0 | |
| 5 | Total profit before tax | 1948820000 | |
| 6 | Tax expense | ||
| 7 | Current tax | 572200000 | |
| 8 | Deferred tax | -138770000 | |
| 9 | Total tax expenses | 433430000 | |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | |
| 11 | Net Profit Loss for the period from continuing operations | 1515390000 | |
| 12 | Profit (loss) from discontinued operations before tax | 0 | |
| 13 | Tax expense of discontinued operations | 0 | |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | |
| 16 | Total profit (loss) for period | 1515390000 | |
| 17 | Other comprehensive income net of taxes | 62280000 | |
| 18 | Total Comprehensive Income for the period | 1577670000 | |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | |||
| Total profit or loss, attributable to non-controlling interests | |||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | |||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 170260000 | ||
| Face value of equity share capital | 1 | ||
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 9.07 | ||
| Diluted earnings (loss) per share from continuing operations | 8.85 | ||
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | ||
| Diluted earnings (loss) per share from discontinued operations | 0 | ||
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 9.07 | ||
| Diluted earnings (loss) per share from continuing and discontinued operations | 8.85 | ||
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
Disclosure of notes on financial results |
|||
|---|---|---|---|
| Textual Information(1) | Notes to the Statement of Unaudited Consolidated and Standalone Financial Results for the quarter ended June 30, 2025ttttttttttt nttttttttttt n1. The above standalone financial results of Inventurus Knowledge Solutions Limited (the Company) and consolidated financial results of the Company and its subsidiaries (collectively the Group) for the quarter ended June 30, 2025 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in it's meeting held on July 31, 2025. The above results for the quarter ended June 30, 2025 have been reviewed by the Statutory Auditors of the Company in terms of Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. The figures for the quarter ended June 30, 2024 as reported in the statement have been approved by the Company's Board of Directors but have not been subjected to limited review since the requirement of submission of quarterly financial results is applicable on listing of equity shares of the Company from the quarter ended December 31, 2024.tttttttttttt n2. The statement has been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder.t nttttttttttt n3. The figures of the quarter ended March 31, 2025 are balancing figures between the audited figures in respect of the full financial year ended on March 31, 2025 and the unaudited published year to date figures upto third quarter ended on December 31, 2024, which were subjected to Limited review by the Statutory Auditors.ttttttttt n4. The Group operates in one reportable business segment which comprises a Care enablement platform providing technology enabled solutions to Healthcare providers. This in the context of Indian Accounting Standard (Ind AS 108) Operating Segments, constitutes a single operating segment.tttttttttttt n5. During the quarter ended June 30, 2025, the Company has allotted 23,942 shares (previous period, 464,800 shares) to eligible employees on exercise of Employee Stock options, in accordance with the terms and conditions of the IKS Employees Stock Options Plan 2022 named IKS Health - ESOP Policy 2022 as approved by the shareholders of the Company on April 22, 2022. Accordingly, the Company has transferred Rs. 3.51 million to the Securities Premium during the quarter ended June 30, 2025. Further, during the quarter ended June 30, 2025, the Company has granted 287,500 stock options respectively to eligible employees, as approved in the Nomination and Remuneration Committee meeting. The related share based compensation expense for the quarter ended June 30, 2025 is Rs.12.70 million.ttttttt ntttttttttt n6. The Board of Directors of the Company at its Meeting held on June 30, 2025, approved investment upto USD 17,000,000 by Inventurus Knowledge Solutions Inc, a subsidiary of the Company in IKS WWMG MSO LLC (Target Company) by subscribing upto 17,000,000 Common Units of the Target Company, which will result in acquisition of 48.02% of the outstanding equity interests of the Target Company by Inventurus Knowledge Solutions Inc. The contractual Purchase Closing Date is July 2, 2025 being the date on which Company has made the required payment as per the Purchase closing terms.tttttttt n7. Earnings per share for the interim periods are not annualised.tttttttttttttt n8. The consolidated financial results of the Group include the results of its subsidiary companies viz: Inventurus Knowledge Solutions Inc, IKS Cares Foundation and its step down subsidiary companies viz: Aquity Holdings Inc, Aquity Solutions LLC, Aquity Solutions India Private Limited, Aquity Solutions Australia Pty Limited and Aquity Canada ULC. | ||
Remarks |
|
|---|---|
| Debt equity ratio | |
| Debt service coverage ratio | |
| Interest service coverage ratio | |
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Apr-2025 | ||||||
| Date of end of reporting period | 30-Jun-2025 | ||||||
| Whether accounts are audited or unaudited | Unaudited | ||||||
| Nature of report standalone or consolidated | Consolidated | ||||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | Textual Information(2) | ||||||
Text Block |
|
|---|---|
| Textual Information(2) | Not Applicable, refere note 4. of the statement of unaudited financial results for the quarter ended June 30, 2025. |
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Apr-2025 | |
| B | Date of end of reporting period | 30-Jun-2025 | |
| C | Whether results are audited or unaudited | Unaudited | |
| D | Nature of report standalone or consolidated | Consolidated | |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of post employment benefit obligations | -14250000 | -14250000 |
| 2 | Changes in the fair value of equity investments at FVOCI | 0 | 0 |
| Total Amount of items that will not be reclassified to profit and loss | -14250000 | ||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | -3750000 | |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Gains/ (losses) on cash flow hedges (net) | 68040000 | 68040000 |
| 2 | Exchange differences on translation of financial statements of foreign operations | 19580000 | 19580000 |
| Total Amount of items that will be reclassified to profit and loss | 87620000 | ||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 14840000 | |
| 5 | Total Other comprehensive income | 62280000 | |